Cell Therapy News Volume 15.22 | Jul 15 2024

    0
    168








    2024-07-15 | CTN 25.22


    Cell Therapy News by STEMCELL Technologies
    Vol. 15.22 – 15 July, 2024
    TOP STORY

    Disruption of TGF-β Signaling Pathway Is Required to Mediate Effective Killing of Hepatocellular Carcinoma by Human iPSC-Derived NK Cells

    The authors used human induced pluripotent stem cells (iPSCs) to produce natural killer (NK) cells engineered to mediate improved anti-HCC activity.
    [Cell Stem Cell]

    AbstractPress ReleaseGraphical Abstract
    PUBLICATIONSRanked by the impact factor of the journal

    Genetic Ablation of Adhesion Ligands Mitigates Rejection of Allogeneic Cellular Immunotherapies

    Scientists demonstrated that genetic deletion of the adhesion ligands CD54 and CD58 in B2M-deficient CAR T cells and multi-edited induced pluripotent stem cell-derived CAR NK cells reduced their susceptibility to rejection by host NK cells in vitro and in vivo.
    [Cell Stem Cell]

    Full ArticleGraphical Abstract

    Self-Powered Triboelectric-Responsive Microneedles with Controllable Release of Optogenetically Engineered Extracellular Vesicles for Intervertebral Disc Degeneration Repair

    The authors fabricated an exercise self-powered triboelectric-responsive microneedle assay with the sustainable release of optogenetically engineered extracellular vesicles for intervertebral disc degeneration repair.
    [Nature Communications]

    Full Article

    Chimeric Antigen Receptor-Induced Antigen Loss Protects CD5.CART Cells from Fratricide without Compromising On-Target Cytotoxicity

    Researchers demonstrated that the expression of a CAR targeting CD5, a prominent pan-T cell antigen, induced rapid internalization and complete loss of the CD5 protein on T cells, protecting them from self-targeting.
    [Cell Reports Medicine]

    Full Article

    CAR Memory–Like NK Cells Targeting the Membrane Proximal Domain of Mesothelin Demonstrate Promising Activity in Ovarian Cancer

    Cytokine-induced memory–like NK cells demonstrated superior antitumor responses against a panel of epithelial ovarian cancer cell lines, increased expression of activation receptors, and up-regulation of genes involved in cell cycle/proliferation and down-regulation of inhibitory/suppressive genes.
    [Science Advances]

    Full Article

    IL-13Rα2/TGF-β Bispecific CAR-T Cells Counter TGF-β–Mediated Immune Suppression and Potentiate Anti-Tumor Responses in Glioblastoma

    Investigators engineered a single-chain, bispecific CAR targeting IL-13Rα2 and TGF-β, which programmed tumor-specific T cells to convert TGF-β from an immunosuppressant to an immunostimulant.
    [Neuro-Oncology]

    Abstract

    Umbilical Cord Blood T Cells Can Be Isolated and Enriched by CD62L Selection for Use in ‘Off the Shelf’ Chimeric Antigen Receptor T Cell Therapies to Widen Transplant Options

    Molecular characterization captured vector integration sites and CRISPR editing signatures and functional studies, including in vivo potency studies in humanised mice, confirmed antileukaemic activity comparable to peripheral blood-derived universal CAR19 T cells.
    [Haematologica]

    Abstract

    Autologous Transplant vs. CAR-T Therapy in Patients with DLBCL Treated While in Complete Remission

    Scientists compared the efficacy of autologous hematopoietic cell transplantation (auto-HCT) vs. CAR-T in patients with DLBCL in complete remission. A retrospective observational study comparing auto-HCT (2015–2021) vs. CAR-T using the Center for International Blood & Marrow Transplant Research registry.
    [Blood Cancer Journal]

    Abstract

    SHP2 Mediates the ROS/JNK/NFAT4 Signaling Pathway in Gastric Cancer Cells Prompting lncRNA SNHG18 to Drive Gastric Cancer Growth and Metastasis via CAR-T Cells

    Researchers utilized subcutaneous tumor models in nude mice to assess gastric cancer progression. Protein expression was detected using Western blotting, while qPCR examined the expression levels of lncRNA SNHG18 and miR-211-5p in MGC-803 cells.
    [Heliyon]

    Full Article
    Get a Head Start with Our New Lab Start-Up Program
    REVIEWS

    Gene Therapy and Gene Editing Strategies in Inherited Blood Disorders

    The authors present an overview of the current landscape of gene therapies, focusing on clinical research and gene therapy products for inherited blood disorders, evaluation of potential gene targets, and the gene editing tools employed in current gene therapy practices.
    [Journal of Genetics and Genomics]

    Abstract
    INDUSTRY AND POLICY NEWS

    Tanoto Foundation Pledges $5 Million to Accelerate Cell Therapy Discovery and Innovation at MD Anderson

    The Tanoto Foundation pledged $5 million to The University of Texas MD Anderson Cancer Center to support cell therapy discovery and innovation research.
    [MD Anderson Cancer Center]

    Full Article

    Bucknell Professor Receives $200,000 Research Grant

    A Bucknell University professor has received nearly $200,000 in grant funding to research therapeutic applications of ultrasound and the expansion of regenerative medicine education for underrepresented college and high school students.
    [The Daily Item]

    Press Release
    FEATURED EVENT

    Engineering Development and Disease in Organoids

    August 19 – 21, 2024
    San Diego, California, United States

    > See All Events

    JOB OPPORTUNITIES

    Supervisor – Cell Therapy Manufacturing

    ElevateBio – Waltham, Massachusetts, United States

    Research Associate – CAR-Treg Therapy

    University of British Columbia – Vancouver, British Columbia, Canada

    Research Associate – CAR T Cell Therapy

    City of Hope – Duarte, California, United States

    Staff Scientist – Immunology

    Baylor College of Medicine – Houston, Texas, United States

    Postdoctoral Positions – Biochemistry

    Goethe University Frankfurt am Main – Frankfurt, Germany

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2